Pituitary Prolactinoma — SCE Neurology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Start cabergoline with endocrine and neuro-ophthalmic monitoring, after confirming the indication
The best answer is “Start cabergoline with endocrine and neuro-ophthalmic monitoring, after confirming the indication”. Dopamine agonist therapy usually lowers prolactin and shrinks even large prolactinomas rapidly; surgery is reserved for selected resistance, intolerance or emergencies. “Proceed directly to trans-sphenoidal surgery in every macroprolactinoma” remains a plausible alternative in a different presentation, but it does not fit the decisive finding or management threshold here. “Use radiotherapy before confirming response to dopamine agonist treatment” remains a plausible alternative in a different presentation, but it does not fit the decisive finding or management threshold here. “Observe until irreversible visual-field loss develops” remains a plausible alternative in a different presentation, but it does not fit the decisive finding or management threshold here. “Treat with somatostatin analogue because prolactin is a growth-hormone marker” remains a plausible alternative in a different presentation, but it does not fit the decisive finding or management threshold here.
Reference: Pituitary Society international consensus statement on prolactinoma: https://pubmed.ncbi.nlm.nih.gov/37670148/